Walter J. Curran Jr, MD
To the Editors: The article by Johnson and colleagues (1) alleges in its title that the Southeastern Cancer Study Group has shown a lack of survival benefit for thoracic radiotherapy among patients with locally advanced non-small cell lung cancer. A careful reading of the article would suggest otherwise.
Of the 272 patients considered evaluable for response, 221 (81%) received either immediate or delayed thoracic radiotherapy as a component of their protocol treatment. This includes 44% to 46% of patients assigned to the vindesine arm who were considered evaluable for survival. When such a major proportion of patients receives a therapy
Walter J. Curran. Effectiveness of Treatment for Non-Small Cell Lung Cancer. Ann Intern Med. 1990;113:637–638. doi: 10.7326/0003-4819-113-8-637
Download citation file:
Published: Ann Intern Med. 1990;113(8):637-638.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use